185 related articles for article (PubMed ID: 8797864)
1. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation.
Matsushita K; Kobayashi S; Kato M; Itoh Y; Okuyama K; Sakiyama S; Isono K
Int J Cancer; 1996 Aug; 69(4):259-64. PubMed ID: 8797864
[TBL] [Abstract][Full Text] [Related]
2. [Messenger RNA expression of p21WAF1/CIP1 in colorectal carcinoma tissues].
Kobayashi S; Matsushita K; Isono K
Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):457-62. PubMed ID: 9742528
[TBL] [Abstract][Full Text] [Related]
3. Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.
Hui AM; Kanai Y; Sakamoto M; Tsuda H; Hirohashi S
Hepatology; 1997 Mar; 25(3):575-9. PubMed ID: 9049201
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
5. [Expression of p21 WAF1/CIP1 protein in colorectal cancers: study of its relation to p53 mutation and Ki67 antigen expression].
Chapusot C; Assem M; Martin L; Chalabreyssse L; Benhamiche AM; Lignier MA; Chauffert B; Teyssier JR; Faivre J; Piard F
Pathol Biol (Paris); 2001 Mar; 49(2):115-23. PubMed ID: 11317955
[TBL] [Abstract][Full Text] [Related]
6. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
[TBL] [Abstract][Full Text] [Related]
7. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
[TBL] [Abstract][Full Text] [Related]
8. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
9. Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.
Ozçelik H; Mousses S; Andrulis IL
Clin Cancer Res; 1995 Aug; 1(8):907-12. PubMed ID: 9816061
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.
Gao X; Chen YQ; Wu N; Grignon DJ; Sakr W; Porter AT; Honn KV
Oncogene; 1995 Oct; 11(7):1395-8. PubMed ID: 7478562
[TBL] [Abstract][Full Text] [Related]
11. p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx.
Nadal A; Jares P; Cazorla M; Fernández PL; Sanjuan X; Hernandez L; Pinyol M; Aldea M; Mallofré C; Muntané J; Traserra J; Campo E; Cardesa A
J Pathol; 1997 Oct; 183(2):156-63. PubMed ID: 9390027
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma.
Furutani M; Arii S; Tanaka H; Mise M; Niwano M; Harada T; Higashitsuji H; Imamura M; Fujita J
Cancer Lett; 1997 Jan; 111(1-2):191-7. PubMed ID: 9022146
[TBL] [Abstract][Full Text] [Related]
13. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
14. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.
Cho JH; Kim WH
Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943
[TBL] [Abstract][Full Text] [Related]
15. Analysis of p21WAF1/CIP1 in primary bladder tumors.
Lacombe L; Orlow I; Silver D; Gerald WL; Fair WR; Reuter VE; Cordon-Cardo C
Oncol Res; 1996; 8(10-11):409-14. PubMed ID: 9114433
[TBL] [Abstract][Full Text] [Related]
16. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
18. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.
Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S
J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083
[TBL] [Abstract][Full Text] [Related]
19. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
[TBL] [Abstract][Full Text] [Related]
20. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
